8897 |
Ab00188-26.0-BT |
Anti-IL-2R alpha (CD25) [Basiliximab] |
1 mg |
支 |
19920.00 |
8898 |
Ab00188-26.0 |
Anti-IL-2R alpha (CD25) [Basiliximab] |
200 μg |
支 |
4680.00 |
8899 |
Ab00188-23.0-BT |
Anti-IL-2R alpha (CD25) [Basiliximab] |
1 mg |
支 |
19920.00 |
8900 |
Ab00188-23.0 |
Anti-IL-2R alpha (CD25) [Basiliximab] |
200 μg |
支 |
4680.00 |
8901 |
Ab00188-2.0-BT |
Anti-IL-2R alpha (CD25) [Basiliximab] |
1 mg |
支 |
19920.00 |
8902 |
Ab00188-2.0 |
Anti-IL-2R alpha (CD25) [Basiliximab] |
200 μg |
支 |
4680.00 |
8903 |
Ab00188-10.3-BT |
Anti-IL-2R alpha (CD25) [Basiliximab] |
1 mg |
支 |
19920.00 |
8904 |
Ab00188-10.3 |
Anti-IL-2R alpha (CD25) [Basiliximab] |
200 μg |
支 |
4680.00 |
8905 |
Ab00188-10.0-BT |
Anti-IL-2R alpha (CD25) [Basiliximab] |
1 mg |
支 |
19920.00 |
8906 |
Ab00188-10.0 |
Anti-IL-2R alpha (CD25) [Basiliximab] |
200 μg |
支 |
4680.00 |
8907 |
Ab00188-1.1-BT |
Anti-IL-2R alpha (CD25) [Basiliximab] |
1 mg |
支 |
19920.00 |
8908 |
Ab00188-1.1 |
Anti-IL-2R alpha (CD25) [Basiliximab] |
200 μg |
支 |
4680.00 |
8909 |
Ab00187-35.0-BT |
Anti-IL-2R [Daclizumab] |
1 mg |
支 |
19920.00 |
8910 |
Ab00187-35.0 |
Anti-IL-2R [Daclizumab] |
200 μg |
支 |
4680.00 |
8911 |
Ab00187-26.0-BT |
Anti-IL-2R [Daclizumab] |
1 mg |
支 |
19920.00 |
8912 |
Ab00187-26.0 |
Anti-IL-2R [Daclizumab] |
200 μg |
支 |
4680.00 |